DERMAPHARM HOLDING SE (DMP.DE) Stock Price, Forecast & Analysis
Europe - FRA:DMP - DE000A2GS5D8 - Common Stock
DMP.DE Key Statistics, Chart & Performance
The current stock price of DMP.DE is 34.375 EUR. In the past month the price increased by 4.56%. In the past year, price decreased by -1.01%.
DMP.DE Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 1SAN.MI | SANOFI | 11.86 | 219.58B | ||
| SNW.DE | SANOFI | 11.8 | 218.39B | ||
| SAN.PA | SANOFI | 11.77 | 217.95B | ||
| MRK.DE | MERCK KGAA | 16.74 | 50.30B | ||
| 1MRK.MI | MERCK KGAA | 13.27 | 49.11B | ||
| UCB.BR | UCB SA | 35.33 | 44.11B | ||
| 1BAYN.MI | BAYER AG-REG | 5.78 | 27.92B | ||
| BAYN.DE | BAYER AG-REG | 5.67 | 27.40B | ||
| REC.MI | RECORDATI INDUSTRIA CHIMICA | 26.52 | 10.93B | ||
| IPN.PA | IPSEN | 12.63 | 10.87B | ||
| TUB.BR | FINANCIERE DE TUBIZE | 95.58 | 8.85B | ||
| VIRP.PA | VIRBAC SA | 20.62 | 3.00B |
Related stock screener links
About DMP.DE
Company Profile
Dermapharm Holding SE engages in the development, manufacture and market of patent-free pharmaceutical products. The company is headquartered in Gruenwald, Bayern and currently employs 3,551 full-time employees. The company went IPO on 2018-02-09. The firm operates through two segments: Branded pharmaceuticals and other healthcare products, which includes in-house development, in-house production, and distribution of branded pharmaceuticals and other healthcare products, and Parallel import business, which operates under the axicorp brand. The company holds around 950 marketing authorizations for more than 250 active pharmaceutical ingredients, which are marketed as pharmaceuticals, dietary supplements or supplemental balanced diets. The firm offers its products through a number of brands, including Dekristol, Ampho Moronal, Keltican, Tromcardin, among others. The company is active primarily in Germany, Switzerland and Austria. Additionally, it operates production facility in Germany. Trommsdorff & GmbH Co KG is a subsidiary of the Company.
Company Info
DERMAPHARM HOLDING SE
Lil-Dagover-Ring 7
Gruenwald BAYERN DE
Employees: 3610
Phone: 4989641860
DERMAPHARM HOLDING SE / DMP.DE FAQ
What does DMP do?
Dermapharm Holding SE engages in the development, manufacture and market of patent-free pharmaceutical products. The company is headquartered in Gruenwald, Bayern and currently employs 3,551 full-time employees. The company went IPO on 2018-02-09. The firm operates through two segments: Branded pharmaceuticals and other healthcare products, which includes in-house development, in-house production, and distribution of branded pharmaceuticals and other healthcare products, and Parallel import business, which operates under the axicorp brand. The company holds around 950 marketing authorizations for more than 250 active pharmaceutical ingredients, which are marketed as pharmaceuticals, dietary supplements or supplemental balanced diets. The firm offers its products through a number of brands, including Dekristol, Ampho Moronal, Keltican, Tromcardin, among others. The company is active primarily in Germany, Switzerland and Austria. Additionally, it operates production facility in Germany. Trommsdorff & GmbH Co KG is a subsidiary of the Company.
What is the current price of DMP stock?
The current stock price of DMP.DE is 34.375 EUR. The price decreased by -0.07% in the last trading session.
Does DERMAPHARM HOLDING SE pay dividends?
DERMAPHARM HOLDING SE (DMP.DE) has a dividend yield of 2.67%. The yearly dividend amount is currently 0.88.
What is the ChartMill rating of DERMAPHARM HOLDING SE stock?
DMP.DE has a ChartMill Technical rating of 4 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
What is the Price/Earnings (PE) ratio of DERMAPHARM HOLDING SE (DMP.DE)?
The PE ratio for DERMAPHARM HOLDING SE (DMP.DE) is 17.27. This is based on the reported non-GAAP earnings per share of 1.99 and the current share price of 34.375 EUR.
What is the expected growth for DMP stock?
The Revenue of DERMAPHARM HOLDING SE (DMP.DE) is expected to decline by -0.58% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
What is the next earnings date for DMP stock?
DERMAPHARM HOLDING SE (DMP.DE) will report earnings on 2026-03-26, after the market close.
DMP.DE Technical Analysis
ChartMill assigns a technical rating of 4 / 10 to DMP.DE. When comparing the yearly performance of all stocks, DMP.DE turns out to be only a medium performer in the overall market: it outperformed 42.49% of all stocks.
DMP.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to DMP.DE. While DMP.DE is still in line with the averages on profitability rating, there are concerns on its financial health.
DMP.DE Financial Highlights
Over the last trailing twelve months DMP.DE reported a non-GAAP Earnings per Share(EPS) of 1.99. The EPS increased by 29.17% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 9.11% | ||
| ROA | 5.02% | ||
| ROE | 17.62% | ||
| Debt/Equity | 1.52 |
DMP.DE Forecast & Estimates
11 analysts have analysed DMP.DE and the average price target is 43.25 EUR. This implies a price increase of 25.81% is expected in the next year compared to the current price of 34.375.
For the next year, analysts expect an EPS growth of 13% and a revenue growth -0.58% for DMP.DE